INTERNATIONAL PATENT: MYRIAD WOMEN'S HEALTH, INC. FILES APPLICATION FOR "USE OF MULTI-NUCLEOTIDE AND STRUCTURAL VARIANTS FOR IMPROVED SENSITIVITY AND SPECIFICITY OF CIRCULATING TUMOR DNA ASSAYS"

GENEVA, May 14 -- MYRIAD WOMEN'S HEALTH, INC. (180 Kimball WaySouth San Francisco, California 94080) filed a patent application (PCT/US2024/053468) for "USE OF MULTI-NUCLEOTIDE AND STRUCTURAL VARIANTS FOR IMPROVED SENSITIVITY AND SPECIFICITY OF CIRCULATING TUMOR DNA ASSAYS" on Oct 29, 2024. With publication no. WO/2025/096476, the details related to the patent application was published on May 08, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): MUZZEY, Dale (c/o Myriad Women's Health, Inc.180 Kimball WaySouth San Francisco, California 94080), GOULD, Genevieve (c/o Myriad Women's Health, Inc.1...